Tysabri review launched in Europe
Tysabri review launched in Europe
In light of growing evidence, the European Medicines Agency (EMA) has been asked to launch a review of the multiple sclerosis drug Tysabri to assess whether advice on managing known risks for progressive multifocal leukoencephalopathy (PML) should be revised.... Read More - http://www.ms-uk.org/tysabri
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1832 Views
-
Last post by frodo
-
- 0 Replies
- 1175 Views
-
Last post by NHE
-
- 0 Replies
- 1656 Views
-
Last post by frodo
-
- 0 Replies
- 1191 Views
-
Last post by frodo
-
- 1 Replies
- 1643 Views
-
Last post by frodo
-
- 0 Replies
- 1966 Views
-
Last post by NHE
-
- 0 Replies
- 955 Views
-
Last post by frodo
-
- 0 Replies
- 1035 Views
-
Last post by frodo
-
- 1 Replies
- 1357 Views
-
Last post by NHE